Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Accepted for publication October 26, 2021
- Published online March 1, 2022.
Article Versions
- Latest version (November 15, 2021 - 04:00).
- Latest version (November 15, 2021 - 14:25).
- Latest version (December 15, 2021 - 04:00).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright © 2022 by the Journal of Rheumatology This is an Open Access article, which permits use, distribution, and reproduction, without modification, provided the original article is correctly cited and is not used for commercial purposes.
Author Information
- Jeffrey R. Curtis1,
- Xiaofeng Zhou2⇑,
- David T. Rubin3,
- Walter Reinisch4,
- Jinoos Yazdany5,
- Philip C. Robinson6,
- Yan Chen2,
- Birgitta Benda2,
- Ann Madsen2 and
- Jamie Geier2
- 1J.R. Curtis, MD, Division of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, Alabama, USA;
- 2X. Zhou, PhD, Y. Chen, MD, B. Benda, MD, PhD, A. Madsen, PhD, J. Geier, PhD, Pfizer Inc, New York, New York, USA;
- 3D.T. Rubin, MD, University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA;
- 4W. Reinisch, MD, Medical University of Vienna, Vienna, Austria;
- 5J. Yazdany, MD, Division of Rheumatology, Department of Medicine, University of California, San Francisco, California, USA;
- 6P.C. Robinson, MBChB, PhD, School of Clinical Medicine, Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia.
- Address correspondence to Dr. X. Zhou, Pfizer Inc, 235 East 42nd Street, New York, NY 10017, USA. Email: xiaofeng.zhou{at}pfizer.com.